Literature DB >> 22768895

Safety and efficacy of mild compression (18-25 mm Hg) therapy in patients with diabetes and lower extremity edema.

Stephanie C Wu1, Ryan T Crews, Bijan Najafi, Nancy Slone-Rivera, Jessica L Minder, Charles A Andersen.   

Abstract

BACKGROUND: Patients with diabetes often present with lower extremity (LE) edema; however, because of concomitant peripheral arterial disease, compression therapy is generally avoided by providers in fear of compromising arterial circulation. This pilot study sought to assess whether diabetic socks with mild compression (18-25 mm Hg) can reduce LE edema in patients with diabetes without negatively impacting vascularity.
METHODS: Eighteen subjects (9 males, 9 females) aged 61 ± 11 years with diabetes, LE edema, and a mean ankle-brachial index (ABI) of 1.10 ± 0.21 successfully completed this uncontrolled study. At baseline, subjects were fitted and instructed to wear the socks during all waking hours. Follow-up visits occurred weekly for four consecutive weeks. Edema was quantified through midfoot, ankle, and calf circumferences and cutaneous fluid measurements. Vascular status was tracked via ABI.
RESULTS: Repeated measures analysis of variance and least significant difference post hoc analyses were used for data analyses. Calf circumferences showed a statistically significant (p < .05) decrease of 1.3 ± 0.28 cm after just one week and remained significantly smaller than baseline throughout the study. Foot circumferences were significantly reduced at week 2 (-0.98 ± 0.35 cm) and remained significantly below baseline for the remainder of the study. The ankle also demonstrated a trend of circumference reduction but was not statistically significant. Cutaneous edema significantly reduced by week 3 (-3.1 ± 1.3 U) and remained so at week 4. Ankle-brachial index significantly increased (0.14 ± 0.049) at week 2 but was not significantly higher at weeks 3 or 4. No adverse events occurred during the study.
CONCLUSIONS: Mild compression therapy (18-25 mm Hg) decreased swelling in diabetes patients with LE edema without compromising vascularity.
© 2012 Diabetes Technology Society.

Entities:  

Mesh:

Year:  2012        PMID: 22768895      PMCID: PMC3440039          DOI: 10.1177/193229681200600319

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  36 in total

1.  Do we need to reappraise our method of interpreting the ankle brachial pressure index?

Authors:  D G Carser
Journal:  J Wound Care       Date:  2001-03       Impact factor: 2.072

2.  Intermittent pneumatic compression (IPC) in the treatment of peripheral arterial occlusive disease (PAOD)--A useful tool or just another device?

Authors:  E Kalodiki; A D Giannoukas
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-12-28       Impact factor: 7.069

3.  Effects of sympathetically induced vasomotion on tissue-capillary fluid exchange.

Authors:  Terumi Sakurai; Naohito Terui
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-05-26       Impact factor: 4.733

4.  Prevalence and clinical profile and management of peripheral arterial disease in elderly patients with diabetes.

Authors:  Carlos Escobar; Ignacio Blanes; Andres Ruiz; David Vinuesa; Manuel Montero; Melchor Rodríguez; Gloria Barbera; Luis Manzano
Journal:  Eur J Intern Med       Date:  2011-03-15       Impact factor: 4.487

5.  A phase 2, double-blind, randomized, placebo-controlled trial of a novel nutritional supplement product to promote healthy skin.

Authors:  Steven H Dayan; John P Arkins; Vinny Sharma; Elaine Paterson; David Barnes
Journal:  J Drugs Dermatol       Date:  2011-10       Impact factor: 2.114

Review 6.  Noninvasive assessment of lower extremity hemodynamics in individuals with diabetes mellitus.

Authors:  Charles A Andersen
Journal:  J Vasc Surg       Date:  2010-09       Impact factor: 4.268

7.  Factors associated with healing leg ulceration with high compression.

Authors:  P J Franks; C J Moffatt; M Connolly; N Bosanquet; M I Oldroyd; R M Greenhalgh; C N McCollum
Journal:  Age Ageing       Date:  1995-09       Impact factor: 10.668

8.  Validation of a new dielectric device to assess changes of tissue water in skin and subcutaneous fat.

Authors:  J Nuutinen; R Ikäheimo; T Lahtinen
Journal:  Physiol Meas       Date:  2004-04       Impact factor: 2.833

9.  Reliability and feasibility of methods to quantitatively assess peripheral edema.

Authors:  Kimberly G Brodovicz; Kristin McNaughton; Naoto Uemura; Gary Meininger; Cynthia J Girman; Steven H Yale
Journal:  Clin Med Res       Date:  2009-02-26

10.  Assessing lymphedema by tissue indentation force and local tissue water.

Authors:  H N Mayrovitz
Journal:  Lymphology       Date:  2009-06       Impact factor: 1.286

View more
  4 in total

1.  Control of lower extremity edema in patients with diabetes: Double blind randomized controlled trial assessing the efficacy of mild compression diabetic socks.

Authors:  Stephanie C Wu; Ryan T Crews; Melissa Skratsky; Julia Overstreet; Sai V Yalla; Michelle Winder; Jacquelyn Ortiz; Charles A Andersen
Journal:  Diabetes Res Clin Pract       Date:  2017-02-27       Impact factor: 5.602

Review 2.  [Indications and contraindications for modern compression therapy].

Authors:  Joachim Dissemond; Martin Storck; Knut Kröger; Markus Stücker
Journal:  Wien Med Wochenschr       Date:  2017-10-20

3.  Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement.

Authors:  Eberhard Rabe; Hugo Partsch; Nick Morrison; Mark H Meissner; Giovanni Mosti; Christopher R Lattimer; Patrick H Carpentier; Sylvain Gaillard; Michael Jünger; Tomasz Urbanek; Juerg Hafner; Malay Patel; Stephanie Wu; Joseph Caprini; Fedor Lurie; Tobias Hirsch
Journal:  Phlebology       Date:  2020-03-02       Impact factor: 1.740

4.  Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease.

Authors:  Ulrich Rother; Anna Grussler; Colin Griesbach; Veronika Almasi-Sperling; Werner Lang; Alexander Meyer
Journal:  BMJ Open Diabetes Res Care       Date:  2020-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.